Anti-Human IL-3 (Clone 4806)

Leinco Technologies
Product Code: LEI-I-630
Product Group: Primary Antibodies
CodeSizePrice
LEI-I-630-25ug25 ug£375.00
Quantity:
LEI-I-630-100ug100 ug£694.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 4806
Regulatory Status: RUO
Target Species: Human
Applications:
  • Immunocytochemistry (ICC)
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody can be stored desiccated at -20°C to -70°C for up to twelve months. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months.

Further Information

Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.4 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Formulation:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.4 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Immunogen:
Purified Recombinant Human IL-3 (Accession # Q6GS87)
Long Description:
IL-3 is a 17 kD pleiotropic cytokine and a member of a family of growth factors that sustains both the proliferation and the development of hematopoietic precursors. It also displays neurotrophic activity and is thought to be associated with neurologic disorders. Signal transmission is assured by high affinity binding to the IL-3 receptor (IL3RA). The receptor contains α and β subunits. IL-3 shares the β subunit with IL-5 and GM-CSF which explains their biological functional similarities. The IL-3/receptor complex induces JAK2/STAT5 cell signalization pathway and it can stimulate both the activation of gene expression and the suppression of apoptosis via transcription factor c-myc and the Ras pathway, respectively. IL-3 fuels the differentiation of multipotent hematopoietic stem cells into myeloid progenitor cells or lymphoid progenitor cells (when in conjunction with IL-7). Together with other cytokines, including EPO, GM-CSF, and IL-6, IL-3 can stimulate proliferation of all cells in the myeloid lineage. The constitutive expression of IL-3 in some leukemia cell lines (as opposed to selective T-cell expression in response to specific impulses or antigens) is thought to fuel the development of the disease. Post-chemotherapy IL-3 application can promote regeneration of granulocytes and platelets. Furthermore, during high-dose chemotherapy, the combination of IL-3, GM-CSF and stem cell factor increases peripheral blood stem cells. IL-3 is thought to have therapeutic potential in lymphohematopoietic disorders and solid cancers.
Target:
IL-3

References

1. Laston, D. et al. (1998) Science 241: 1820

Related Products

Product NameProduct CodeSupplier 
Anti-Mouse IL-3LEI-I-163Leinco Technologies Summary Details
Recombinant Human IL-3LEI-I-185Leinco Technologies Summary Details
Recombinant Mouse IL-3LEI-I-206Leinco Technologies Summary Details
Anti-Human IL-3 - BiotinLEI-I-249Leinco Technologies Summary Details
Anti-Mouse IL-3 - BiotinLEI-I-250Leinco Technologies Summary Details
Recombinant Rat IL-3LEI-I-281Leinco Technologies Summary Details
Anti-Human IL-3 (Clone 4815)LEI-I-686Leinco Technologies Summary Details
Anti-Human Interleukin 3 (IL-3) - BiotinLEI-I-758Leinco Technologies Summary Details